Company overview
Genomics England partners with the NHS to provide whole genome sequencing for patients with cancer and rare diseases, enabling precise diagnostics and treatment. They offer a secure Research Environment where de-identified genomic and clinical data supports biotech and academic researchers in discovering new therapies. Their bioinformatics tools and platforms drive genomic research, contributing to the UK Life Sciences Vision.
Genomics England is listed in the NovaPharmaNews Supplier Hub as a Diagnostics & Testing, Software & Digital Lab partner serving United States & Americas. Core focus areas include genomic sequencing, whole genome analysis, nhs genomics, research environment, bioinformatics tools.
Industry categories: Diagnostics & Testing, Software & Digital Lab. These tags help R&D, manufacturing, and procurement teams discover vendors aligned with their pipeline stage and compliance requirements.
Structured facts
- Website
- https://www.genomicsengland.co.uk
- Categories
- Diagnostics & Testing, Software & Digital Lab
- Markets served
- United States & Americas
- Keywords
- genomic sequencing, whole genome analysis, nhs genomics, research environment, bioinformatics tools
Products & technologies
Markets served
Industry categories
Company timeline
- — Profile published on NovaPharmaNews
- — Profile last updated
Related suppliers in category
Frequently asked questions
- What genomic services do you provide to the NHS?
- Genomics England provides whole genome sequencing insights for patients with cancer and rare diseases, along with platforms to support accurate diagnosis, effective treatment, and early detection in partnership with the NHS.
- How can researchers access your genomic data?
- Researchers access de-identified genomic and clinical data through the Genomics England Research Environment, a secure platform that enables analysis for new diagnostics and therapies while maintaining patient privacy.
- What are your key focus areas in genomic research?
- Key areas include cancer, rare diseases, newborn sequencing, and diversifying genomic data, with bioinformatics tools to interpret genetic variation and drive personalized medicine.
Related editorial coverage
- $2M Gene Therapy Cures Need a Financing Model
- A Secure And Intelligent Drug Delivery Model Integrating Neural Networks With Blockchain
- AACR 2024: Daily Oncology Research Roundup
- AACR 2024: Oncology News & Key Takeaways - Day 1
- AACR 2024: Oncology Research Highlights - Day 1 Roundup
- AACR 2026: AI Pathology & Oncolytic Virus Spark Interest
Explore lab tools and QA/QC resources for R&D teams.
